Emergency Medicine in Tulare, CA
5 verified emergency medicine doctors in Tulare.
Emergency physicians provide immediate care for acute illness and injury in the emergency department.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. Ronald Ostrom, DO
Emergency Medicine
CMS Open Payments· $52,145 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$52,145
Total received
8
Transactions
6
Paying companies
Top paying companies
Among the 70,367 emergency medicine doctors we've analyzed, about 18% received any industry payment (median $60 among those who did). This doctor's total is higher than 100% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US emergency medicine doctors.
Payments to Ronald Ostrom do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Ronald Smith, MD
Emergency Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Harold Boulton, MD
Emergency Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Niklas Eriksson, MD
Emergency Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. David Castro Palomino, DO
Emergency Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.